GlassScriptPhysician profile
Jairo A Melo
NPI 1912904079
$22,350.16
in general payments reported to CMS, 2019-2025
50 companies · $2,473 in 2025
The $2,473 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,480 · 2020: $1,176 · 2021: $2,437 · 2022: $3,636 · 2023: $2,942 · 2024: $2,207 · 2025: $2,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,518 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,518.44 |
| Education | $102.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $8,620.88 | 2019-2025 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $2,414.93 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,106.43 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Medtronic, INC. | $955.05 | 2021-2025 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $952.21 | 2021-2023 | Xarelto |
| Abbott Laboratories | $656.14 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $616.35 | 2019-2025 | Ofev, Jascayd |
| Mylan Specialty L.P. | $560.03 | 2019-2024 | Yupelri |
| Intuitive Surgical, INC. | $522.22 | 2019-2023 | Da Vinci Surgical System |
| Abiomed | $507.13 | 2021-2022 | |
| Genzyme Corporation | $485.00 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $483.17 | 2023-2025 | Winrevair |
| United Therapeutics Corporation | $333.82 | 2019-2025 | Tyvaso, Tyvaso |
| Inari Medical, INC. | $320.26 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $278.46 | 2022-2025 | General - Thrombectomy |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $275.60 | 2020-2025 | Spiration Valve System |
| Fresenius USA Marketing, INC. | $220.16 | 2024 | Novalung System |
| Michigan Critical Care Consultants, INC. | $211.05 | 2021 | |
| Grifols USA, LLC | $198.19 | 2019-2023 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $194.32 | 2019-2025 | Dupixent |
| Penumbra, INC. | $185.05 | 2024-2025 | Indigo System |
| Imperative Care, INC | $164.45 | 2025 | Symphony Catheter |
| Pulmonx Corporation | $145.86 | 2022 | |
| Gilead Sciences, INC. | $138.99 | 2019-2023 | Veklury |
| Zoll Respicardia, INC. | $132.85 | 2019 | |
| Globus Medical, INC. | $132.82 | 2025 | Senza |
| Sanofi-Aventis U.S. LLC | $124.36 | 2025 | |
| Getinge USA Sales, LLC | $117.69 | 2021 | |
| Insmed, INC. | $107.45 | 2022-2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $104.83 | 2019-2020 | |
| Angiodynamics, INC. | $103.07 | 2024 | Alphavac |
| Medtronic Vascular, INC. | $99.98 | 2019 | |
| Ekos Corporation | $97.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $93.86 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.70 | 2019-2024 | |
| Sandoz INC. | $84.29 | 2019-2023 | Treprostinil |
| Baxter Healthcare | $77.28 | 2022-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Verona Pharma, INC. | $71.04 | 2025 | Ohtuvayre |
| Amgen INC. | $70.23 | 2023-2025 | Tezspire |
| Viatris Specialty LLC | $42.91 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $40.34 | 2024-2025 | Acthar |
| Philips North America LLC | $36.26 | 2022-2023 | |
| Electromed, INC. | $33.39 | 2023 | Smartvest |
| Advanced Respiratory, INC | $29.26 | 2020-2021 | |
| Abbvie INC. | $27.41 | 2025 | |
| Paratek Pharmaceuticals, INC. | $23.20 | 2023 | Nuzyra |
| Sunovion Pharmaceuticals INC. | $18.31 | 2019 | |
| Jazz Pharmaceuticals INC. | $18.05 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.04 | 2022 | |
| Circassia INC. | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jairo Melo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.